The table below ranks the stock market's five biggest companies (as measured by market cap) as of the end of 2010.

A beat-and-raise fiscal third quarter was the fuel driving Blue Bird ( BLBD 5.56%) stock forward this week. Thanks mostly to ...

Gartner's slowing contract growth sent the stock plunging this week. Shares of Gartner ( IT -0.17%) cratered this week, ...

What's the key to achieving financial freedom? And what's the real risk investors face? In this podcast, Motley Fool analyst ...

Investors and analysts have gotten more bullish on Peloton stock following the company's recent quarterly report.

Investors might have liked to see that statement bolstered by a guidance raise. However, Iovance stuck to its existing forecast of $250 million to $300 million anchored, of course, by Amtagvi. The ...

Rocket Lab's second-quarter results were enough to support gains today, but the stock couldn't hold on to its explosive early rally.

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a mini-rally that extended into Friday; the company's share price added nearly 5% ...

Curious about DoorDash's future in the competitive delivery market? Our experts break down the numbers and share their ...

In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this year. The company now expects full-year revenue to come in at roughly $1.26 ...

Biotech Nektar Therapeutics ( NKTR 6.02%) unveiled its latest quarterly earnings after the stock market's close on Thursday, and the investor reaction was strong the following day. Happily for Nektar, ...

Shares of Eli Lilly ( LLY -2.37%) sank 18% this week, according to data from S&P Global Market Intelligence. The drugmaker with a market cap of over $500 billion is in a sharp drawdown due to ...